OVID THERAPEUTC - 48 Year Dividend History | OVID

Historical dividend payout and yield for OVID THERAPEUTC (OVID) since 1971. The current TTM dividend payout for OVID THERAPEUTC (OVID) as of July 19, 2019 is $0.00. The current dividend yield for OVID THERAPEUTC as of July 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.094B $0.000B
Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company's product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved in developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.508B 12.38
Gilead Sciences (GILD) United States $85.686B 10.40
CSL (CSLLY) Australia $36.043B 0.00
Bio-Techne Corp (TECH) United States $8.121B 55.41